Global Sevoflurane, Isoflurane and Desflurane Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
- SKU ID : GIR-GIR1806210030 13056294
- |
- Publishing Date: 26-Oct-2018
- |
- Region: Global
- |
- No. of pages: 113
Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset and offset.
Isoflurane is a general anesthetic. It can be used to start or maintain anesthesia. Often another medication is used to start anesthesia due to airway irritation with isoflurane. It is used by inhalation.
Desflurane is a highly fluorinated methyl ethyl ether used for maintenance of general anesthesia. Like halothane, enflurane, and isoflurane, it is a racemic mixture of (R) and (S) optical isomers (enantiomers). Together with sevoflurane, it is gradually replacing isoflurane for human use, except in economically undeveloped areas, where its high cost precludes its use. It has the most rapid onset and offset of the volatile anesthetic drugs used for general anesthesia due to its low solubility in blood.
Scope of the Report:
This report focuses on the Sevoflurane, Isoflurane and Desflurane in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Increasing prevalence of cardiovascular and respiratory diseases and population growth are expected to fuel the market. The large amount of evoflurane, isoflurane and desflurane need to be used to help patients reduce pain. Cataract surgery is a major contributor to the global market. A major factor hindering the market is the quantity of CO2 released in the environment, leading to global warming. The United States occupies the biggest share in the worldwide inhalation anesthesia market in 2014. Asia Pacific will experience the fastest growth owing to the rise of chronic diseases and demand for better health infrastructure in the region.
The worldwide market for Sevoflurane, Isoflurane and Desflurane is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
AbbVie
Baxter
Lunan Pharmaceutical Group
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Sevoflurane
Isoflurane
Desflurane
Market Segment by Applications, can be divided into
Cardiovascular Diseases
Respiratory Diseases
Cancer Diseases
Orthopedic Diseases
Spinal Diseases
Gastro-Intestinal Diseases
There are 15 Chapters to deeply display the global Sevoflurane, Isoflurane and Desflurane market.
Chapter 1, to describe Sevoflurane, Isoflurane and Desflurane Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Sevoflurane, Isoflurane and Desflurane, with sales, revenue, and price of Sevoflurane, Isoflurane and Desflurane, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Sevoflurane, Isoflurane and Desflurane, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Sevoflurane, Isoflurane and Desflurane market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Sevoflurane, Isoflurane and Desflurane sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Isoflurane is a general anesthetic. It can be used to start or maintain anesthesia. Often another medication is used to start anesthesia due to airway irritation with isoflurane. It is used by inhalation.
Desflurane is a highly fluorinated methyl ethyl ether used for maintenance of general anesthesia. Like halothane, enflurane, and isoflurane, it is a racemic mixture of (R) and (S) optical isomers (enantiomers). Together with sevoflurane, it is gradually replacing isoflurane for human use, except in economically undeveloped areas, where its high cost precludes its use. It has the most rapid onset and offset of the volatile anesthetic drugs used for general anesthesia due to its low solubility in blood.
Scope of the Report:
This report focuses on the Sevoflurane, Isoflurane and Desflurane in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Increasing prevalence of cardiovascular and respiratory diseases and population growth are expected to fuel the market. The large amount of evoflurane, isoflurane and desflurane need to be used to help patients reduce pain. Cataract surgery is a major contributor to the global market. A major factor hindering the market is the quantity of CO2 released in the environment, leading to global warming. The United States occupies the biggest share in the worldwide inhalation anesthesia market in 2014. Asia Pacific will experience the fastest growth owing to the rise of chronic diseases and demand for better health infrastructure in the region.
The worldwide market for Sevoflurane, Isoflurane and Desflurane is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
AbbVie
Baxter
Lunan Pharmaceutical Group
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Sevoflurane
Isoflurane
Desflurane
Market Segment by Applications, can be divided into
Cardiovascular Diseases
Respiratory Diseases
Cancer Diseases
Orthopedic Diseases
Spinal Diseases
Gastro-Intestinal Diseases
There are 15 Chapters to deeply display the global Sevoflurane, Isoflurane and Desflurane market.
Chapter 1, to describe Sevoflurane, Isoflurane and Desflurane Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Sevoflurane, Isoflurane and Desflurane, with sales, revenue, and price of Sevoflurane, Isoflurane and Desflurane, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Sevoflurane, Isoflurane and Desflurane, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Sevoflurane, Isoflurane and Desflurane market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Sevoflurane, Isoflurane and Desflurane sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
